Clinical Trials

Disease or Condition	Heart / Stent
Title	Evaluation of drug (Everolimus) coated stent (Heart / Stent)
Description	The primary objective of this study is to evaluate clinical outcomes in patients who receive the FDA-approved XIENCE V Everolimus Eluting Coronary Stent System (EECSS) over a five year period post surgery.
IRB Number	Pro239
Inclusion/Notes	INCLUSION: Patients who understand English and receive only XIENCE V EECSS stent(s). EXCLUSION: Patients who don’t understand English and patients who receive other types of stents.
Status	Active - not Recruiting
Location	Texas Health Presbyterian Hospital Dallas
Principal Name	Vinit Rashbihari Lal MD
Contact Name	Shelley Long
Phone	(214) 345-8131